Semaglutide
GLP-1 Receptor Agonist Peptide for Metabolic & Endocrine Signaling Research
- Third-party tested
- COA available
- Lyophilized research material
Description
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 investigated for its activity at the GLP-1 receptor (GLP-1R). Its extended stability in experimental systems has made it an important compound in metabolic and endocrine signaling research.
$50.00/ 10 mg · USD
Volume pricing
Applied automatically in the cart
| Quantity | Per unit | You save |
|---|---|---|
| 3–4 units | $47.50 | −5% |
| 5–9 units | $45.00 | −10% |
| 10+ units | $42.50 | −15% |
Add 2 more to save 5% on every unit.
SKU VP-SEMA-10
Lab search code Viop2610060529
Purity stated per lot
Figures are reported against the lot they belong to, never as a brand average. The analysis for a batch is published on that batch’s certificate.
- Certificate published for each batch
- Third-party tested
- Orders over $200 ship free
- Supplied for laboratory research use only
Complete your protocol
Lyophilized vials are supplied dry. Add the accompanying laboratory supplies in one step.
- SemaglutideThis item
Nothing selected
$0.00
Supplied as laboratory materials for research use only.
Scientific overview
Semaglutide is commonly classified as a long-acting GLP-1 receptor agonist. It is a modified analog of native glucagon-like peptide-1, structurally altered to resist enzymatic degradation and to bind albumin, which extends its persistence in experimental systems. GLP-1R, the Glucagon-Like Peptide-1 Receptor, is studied in glucose-dependent endocrine signaling, nutrient sensing, pancreatic signaling, and central metabolic pathways. Its single-receptor selectivity allows researchers to isolate GLP-1 receptor signaling within an experimental model.
Research applications
- GLP-1 receptor signaling
- Incretin biology
- Metabolic signaling
- Nutrient-sensing pathways
- Pancreatic signaling models
- Endocrine communication
- Cellular receptor activation
- Peptide stability research
- Energy-homeostasis research
Research use & regulatory disclaimer
All products offered by viopep are intended solely for laboratory research and analytical purposes. viopep products are not intended for human or veterinary use or consumption.
Products offered by viopep have not been approved by the U.S. Food and Drug Administration (FDA) for the diagnosis, treatment, cure, mitigation, or prevention of any disease or medical condition. Products are not intended to be used as drugs, food products, dietary supplements, cosmetics, or household products.
Information provided on this website is for general informational and research purposes only. Nothing on this website is intended to constitute medical advice, diagnosis, treatment recommendations, dosing instructions, or guidance regarding human or veterinary use.
By purchasing from viopep, the purchaser acknowledges that products are intended solely for legitimate research purposes and agrees to use and handle all products in accordance with applicable laws, regulations, and appropriate laboratory safety procedures.
Specifications
| Compound | Semaglutide |
|---|---|
| Compound Type | Synthetic peptide analog |
| Primary Target | GLP-1R |
| Research Category | Metabolic & Endocrine Signaling |
| Catalog strengths | 10 mg / 20 mg / 30 mg |
| SKU | VP-SEMA-10 / VP-SEMA-20 / VP-SEMA-30 |
| Purity | Published on the certificate for each batch |
| Analytical method | Published on the certificate for each batch |
| Testing laboratory | Published on the certificate for each batch |
| Form | Lyophilized research material |
Storage and handling
Store lyophilized at -20°C; protect from light and moisture. Reconstitute with bacteriostatic water; refrigerate reconstituted solution at 2-8°C.